Literature DB >> 32099034

Reinstated p53 response and high anti-T-cell leukemia activity by the novel alkylating deacetylase inhibitor tinostamustine.

S Pützer1,2,3, L Varghese1,2,3, J von Jan1,2,3, T Braun1,2,3, A K Giri4, P Mayer1,2,3, N Riet1,3, S Timonen4,5,6,7, S Oberbeck1,2,3, H Kuusanmäki4,5,6,7, S Mustjoki5,6,7, M-H Stern8, T Aittokallio4,9, S Newrzela10, A Schrader1,2,3, M Herling11,12,13.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32099034     DOI： 10.1038/s41375-020-0772-6

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  1 in total

Review 1.  Multimodal HDAC Inhibitors with Improved Anticancer Activity.

Authors:  Rainer Schobert; Bernhard Biersack
Journal:  Curr Cancer Drug Targets       Date:  2018       Impact factor: 3.428
  1 in total
  6 in total

Review 1.  Genetic Alterations in Adult T-Cell Leukemia/Lymphoma: Novel Discoveries with Clinical and Biological Significance.

Authors:  Shugo Sakihama; Kennosuke Karube
Journal:  Cancers (Basel)       Date:  2022-05-12       Impact factor: 6.575

2.  Development of HDAC Inhibitors Exhibiting Therapeutic Potential in T-Cell Prolymphocytic Leukemia.

Authors:  Krimo Toutah; Nabanita Nawar; Sanna Timonen; Helena Sorger; Yasir S Raouf; Shazreh Bukhari; Jana von Jan; Aleksandr Ianevski; Justyna M Gawel; Olasunkanmi O Olaoye; Mulu Geletu; Ayah Abdeldayem; Johan Israelian; Tudor B Radu; Abootaleb Sedighi; Muzaffar N Bhatti; Muhammad Murtaza Hassan; Pimyupa Manaswiyoungkul; Andrew E Shouksmith; Heidi A Neubauer; Elvin D de Araujo; Tero Aittokallio; Oliver H Krämer; Richard Moriggl; Satu Mustjoki; Marco Herling; Patrick T Gunning
Journal:  J Med Chem       Date:  2021-06-08       Impact factor: 7.446

3.  Advances and Perspectives in the Treatment of T-PLL.

Authors:  Till Braun; Jana von Jan; Linus Wahnschaffe; Marco Herling
Journal:  Curr Hematol Malig Rep       Date:  2020-04       Impact factor: 3.952

4.  Patient-tailored design for selective co-inhibition of leukemic cell subpopulations.

Authors:  Aleksandr Ianevski; Jenni Lahtela; Komal K Javarappa; Philipp Sergeev; Bishwa R Ghimire; Prson Gautam; Markus Vähä-Koskela; Laura Turunen; Nora Linnavirta; Heikki Kuusanmäki; Mika Kontro; Kimmo Porkka; Caroline A Heckman; Pirkko Mattila; Krister Wennerberg; Anil K Giri; Tero Aittokallio
Journal:  Sci Adv       Date:  2021-02-19       Impact factor: 14.136

5.  Hijacking the Pathway: Perspectives in the Treatment of Mature T-cell Leukemias.

Authors:  Linus Wahnschaffe; Marco Herling
Journal:  Hemasphere       Date:  2021-06-01

Review 6.  Prospects for Epigenetic Targeted Therapies of Bone and Soft-Tissue Sarcomas.

Authors:  Jun Wang; Arielle Elkrief; Wei Guo; Neerav Shukla; Mrinal Gounder; Marc Ladanyi
Journal:  Sarcoma       Date:  2021-07-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.